149 related articles for article (PubMed ID: 29261620)
1. 68Ga-PSMA Avid Primary Adenocarcinoma of the Lung With Complementary Low 18F-FDG Uptake.
Jochumsen MR; Gormsen LC; Nielsen GL
Clin Nucl Med; 2018 Feb; 43(2):117-119. PubMed ID: 29261620
[TBL] [Abstract][Full Text] [Related]
2. Intertumoral Heterogeneity of 18F-FDG and 68Ga-PSMA Uptake in Prostate Cancer Pulmonary Metastases.
Perez PM; Hope TA; Behr SC; van Zante A; Small EJ; Flavell RR
Clin Nucl Med; 2019 Jan; 44(1):e28-e32. PubMed ID: 30394930
[TBL] [Abstract][Full Text] [Related]
3. Non-Prostate-Specific Membrane Antigen-Avid Metastatic Lung Nodule From Primary Prostatic Adenocarcinoma.
Shetty D; Loh H; Bui C; Mansberg R; Hadjashrafi A; Do V
Clin Nucl Med; 2016 Oct; 41(10):776-8. PubMed ID: 27556788
[TBL] [Abstract][Full Text] [Related]
4. Adenocarcinoma Prostate With Neuroendocrine Differentiation: Potential Utility of 18F-FDG PET/CT and 68Ga-DOTANOC PET/CT Over 68Ga-PSMA PET/CT.
Parida GK; Tripathy S; Datta Gupta S; Singhal A; Kumar R; Bal C; Shamim SA
Clin Nucl Med; 2018 Apr; 43(4):248-249. PubMed ID: 29474196
[TBL] [Abstract][Full Text] [Related]
5. Complimentary Pattern of Uptake in 18F-FDG PET/CT and 68Ga-Prostate-Specific Membrane Antigen PET/CT in a Case of Metastatic Clear Cell Renal Carcinoma.
Sasikumar A; Joy A; Nanabala R; Unni M; Tk P
Clin Nucl Med; 2016 Dec; 41(12):e517-e519. PubMed ID: 27749421
[TBL] [Abstract][Full Text] [Related]
6. Evidence of Prostate-Specific Membrane Antigen Expression in Metastatic Differentiated Thyroid Cancer Using 68Ga-PSMA-HBED-CC PET/CT.
Verma P; Malhotra G; Agrawal R; Sonavane S; Meshram V; Asopa RV
Clin Nucl Med; 2018 Aug; 43(8):e265-e268. PubMed ID: 29894335
[TBL] [Abstract][Full Text] [Related]
7. Complementary Role of 68Ga-Prostate-Specific Membrane Antigen and 18F-FDG PET/CT for Evaluation of Metastases and Treatment Response in Renal Cell Carcinoma.
Has Simsek D; Civan C; Erdem S; Sanli Y
Clin Nucl Med; 2021 Jul; 46(7):579-581. PubMed ID: 33782292
[TBL] [Abstract][Full Text] [Related]
8. Heterogeneous Uptake of 18F-FDG and 68Ga-PSMA-11 in Hepatocellular Carcinoma.
Perez PM; Flavell RR; Kelley RK; Umetsu S; Behr SC
Clin Nucl Med; 2019 Mar; 44(3):e133-e135. PubMed ID: 30624275
[TBL] [Abstract][Full Text] [Related]
9. Different Appearances of 3 Malignancies in 68Ga-PSMA-11 Versus 18F-FDG PET/CT.
Weitzer F; Nazerani-Hooshmand T; Aigner RM; Pernthaler B
Clin Nucl Med; 2021 Jul; 46(7):e358-e359. PubMed ID: 34081054
[TBL] [Abstract][Full Text] [Related]
10. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
11. Small Cell Transformation of Metastatic Prostate Adenocarcinoma Diagnosed by Dual-Tracer PET/CT (
Parghane R; Basu S
J Nucl Med Technol; 2019 Mar; 47(1):85-87. PubMed ID: 30139889
[TBL] [Abstract][Full Text] [Related]
12. FDG-PET Versus PSMA-PET: A Patient With Prostate Cancer.
Kichloo A; Amir R; Aljadah M; Wani F; Solanki S; Singh J; Chugh SS
J Investig Med High Impact Case Rep; 2020; 8():2324709620941313. PubMed ID: 32646251
[TBL] [Abstract][Full Text] [Related]
13. 18F-FDG, 68Ga-DOTATATE and 68Ga-PSMA Positive Metastatic Large Cell Neuroendocrine Prostate Tumor.
Acar E; Kaya GÇ
Clin Nucl Med; 2019 Jan; 44(1):53-54. PubMed ID: 30325820
[TBL] [Abstract][Full Text] [Related]
14. Prostate-Specific Membrane Antigen Expression in Adrenocortical Carcinoma on 68Ga-Prostate-Specific Membrane Antigen PET/CT.
Arora S; Damle NA; Aggarwal S; Passah A; Behera A; Arora G; Bal C; Tripathi M
Clin Nucl Med; 2018 Jun; 43(6):449-451. PubMed ID: 29578871
[TBL] [Abstract][Full Text] [Related]
15. 68Ga-Prostate-Specific Membrane Antigen PET/CT and 18F-FDG PET/CT of Primary Signet Ring Cell Breast Adenocarcinoma.
Parihar AS; Mittal BR; Sood A; Basher RK; Singh G
Clin Nucl Med; 2018 Nov; 43(11):e414-e416. PubMed ID: 30247208
[TBL] [Abstract][Full Text] [Related]
16. Metastases From Colorectal Cancer Avid on 68Ga-PSMA PET/CT.
Hangaard L; Jochumsen MR; Vendelbo MH; Bouchelouche K
Clin Nucl Med; 2017 Jul; 42(7):532-533. PubMed ID: 28525451
[TBL] [Abstract][Full Text] [Related]
17. Incidental Detection of Metastatic Malignant Melanoma on 68Ga-Prostate-Specific Membrane Antigen PET/CT Imaging: Correlative Imaging With FDG PET/CT and Review of the Literature.
Anconina R; Hod N; Levin D; Ezroh Kazap D; Lantsberg S
Clin Nucl Med; 2018 Mar; 43(3):204-206. PubMed ID: 29293137
[TBL] [Abstract][Full Text] [Related]
18. 68 Ga-PSMA-11 and 18 F-FDG PET/CT in a Case of Ductal Adenocarcinoma of the Prostate.
Qiu S; Dong A; Zhu Y; Zuo C
Clin Nucl Med; 2022 Sep; 47(9):836-838. PubMed ID: 35439204
[TBL] [Abstract][Full Text] [Related]
19. Metastatic Poorly Differentiated Thyroid Cancer With Heterogeneous Distribution of 18F-FDG, 68Ga-DOTATATE, and 68Ga-PSMA on PET/CT.
Civan C; Isik EG; Simsek DH
Clin Nucl Med; 2021 Apr; 46(4):e212-e213. PubMed ID: 33156050
[TBL] [Abstract][Full Text] [Related]
20. Primary Hepatocellular Carcinoma With Intense 68Ga-PSMA Uptake But Slight 18F-FDG Uptake on PET/CT Imaging.
Erhamamci S; Aslan N
Clin Nucl Med; 2020 Mar; 45(3):e176-e177. PubMed ID: 31977478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]